Up Nearly 500% in 1 Year, Can Intel Stock Keep Rising on the Artificial Intelligence (AI) Updraft?

Intel shares are up 225% year to date and 498% over the past 12 months as investors bet on AI-driven demand and a potential rebound in its foundry business. The article cites 7% year-over-year Q1 revenue growth to $13.58 billion, above the $12.42 billion estimate, but notes continuing competitive pressure in CPUs and a $2.4 billion foundry loss on $5.4 billion of revenue. Longer term, Intel could benefit from AI CPU demand and customer diversification away from Taiwan, but profitability and valuation remain major risks at 10x sales and 110x expected earnings.

Analysis

The market is pricing Intel less as a cyclical CPU vendor and more as a quasi-sovereign AI infrastructure option, which is a dangerous transition because the upside now depends on two different execution curves moving in sync: product competitiveness and foundry credibility. The second-order winner is likely not Intel alone but the entire domestic supply-chain ecosystem if U.S. customers continue to pre-buy geopolitical redundancy; that creates a relative tailwind for equipment, specialty materials, and advanced packaging capacity, while structurally pressuring the share of wallet that would otherwise remain with TSM. The key implication is that this is not a pure semiconductor-beta trade anymore — it is a policy-and-capex trade with much longer payback periods than the equity market is currently discounting.

The biggest near-term risk is that Intel’s valuation has already pulled forward a multi-year turnaround, leaving little room for “good but not great” quarters. If CPU share gains remain incremental and third-party foundry revenue ramps only slowly, the stock can derate hard because the market is paying for a steep earnings inflection that may not arrive until 2026+; that makes the setup asymmetrically vulnerable to any guide-down on gross margin, capex intensity, or foundry utilization. The other hidden risk is that every incremental foundry win for Intel may initially cannibalize internal manufacturing economics less than investors expect, meaning headline revenue can rise while true economic profit remains negative for several more quarters.

Contrarian read: the consensus is underestimating how much of the AI stack remains attached to x86 CPUs rather than GPUs, which supports Intel’s core franchise, but it is probably overestimating how quickly that translates into durable free cash flow. AMD and ARM face the most obvious multiple compression risk if Intel’s domestic-manufacturing narrative starts pulling design wins back toward x86-compatible ecosystems, yet that pressure will likely show up first in forward order commentary rather than reported revenue. In other words, the trade is not about whether Intel can win some business; it is about whether the market is overpaying for the timing and margin profile of those wins.

Key Decisions for Investors

• Stay long INTC only as a tactical momentum/relative-value position, not a core fundamental long; use a 3-6 month horizon and trim on any further multiple expansion because the stock is already discounting a 2026+ inflection.
• Pair trade: long INTC / short AMD over the next 1-2 quarters into earnings, targeting share-shift headlines and relative multiple compression if Intel stabilizes CPU demand while AMD’s premium valuation remains sensitive to any AI deceleration.
• Use INTC call spreads rather than outright shares for upside exposure; structure 6-12 month maturities to capture a foundry-win rerating while defining downside if utilization or gross margin disappoints.
• Fade the foundry enthusiasm with TSM vs. INTC relative exposure: short TSM only on a basket/pair basis against INTC if you want geopolitical hedging, since Intel’s incremental wins can still be compatible with TSM’s structural lead.
• Watch AAPL and GOOGL for follow-through on domestic sourcing and custom silicon sourcing shifts; if more spending migrates to U.S.-anchored supply chains, the better risk/reward may be in equipment and packaging names rather than INTC itself.